Cargando…
Rapamycin as longevity enhancer and cancer preventative agent in the context of p53 deficiency
Autor principal: | Donehower, Lawrence A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517935/ https://www.ncbi.nlm.nih.gov/pubmed/23128359 |
Ejemplares similares
-
Longevity regulation in flies: A role for p53
por: Donehower, Lawrence A.
Publicado: (2009) -
p53: Pro-aging or pro-longevity?
por: de Keizer*, Peter L.J., et al.
Publicado: (2010) -
Longevity, aging and rapamycin
por: Ehninger, Dan, et al.
Publicado: (2014) -
Forever young? Exploring the link between rapamycin, longevity and cancer
por: Van Meter, Michael, et al.
Publicado: (2012) -
Rapamycin for longevity: opinion article
por: Blagosklonny, Mikhail V.
Publicado: (2019)